Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Navigating the Changing Multiple Myeloma (MM) Treatment Landscape: Real-World Data on Clinical Practice Patterns in 287 MM Patients Treated in and Outside German DSMM (Deutsche Studiengruppe Multiples Myelom) Study Group Trials

Laura Gengenbach, Heike Reinhardt, PhD, Stefanie Ajayi, Pharmacist, Magdalena Szymaniak-Vits, Pharmacist, Martin Köhler, MSc, Stefan J. Müller, PharmD, Sandra M. Dold, MSc, Martin J. Hug, PhD, Markus Ruch, Martin Boeker, PD, Hermann Einsele, Justus Duyster, Ralph Wäsch, MD, Monika Engelhardt

Blood (2017) 130 (Supplement 1): 3105.

https://doi.org/10.1182/blood.V130.Suppl_1.3105.3105

Published: 2017

Journal Articles

Epigenetic Modifications of the Bone Marrow (BM) Niche in Multiple Myeloma (MM) - a Three-Dimensional (3D) in Vitro Approach

Stefan J. Müller, PharmD, Dagmar Wider, Andreas R. Thomsen, MD, Marie Follo, PhD, Johannes M. Waldschmidt, MD, Gabriele Ihorst, Sandra M. Dold, MSc, Julia Felthaus, Johanna Senger, PhD, Julia Schüler, DVM, Justus Duyster, Abdel Kareem Azab, PhD, Martin J. Hug, PhD, Manfred Jung, PhD, Ralph Wäsch, MD, Monika Engelhardt

Blood (2017) 130 (Supplement 1): 1793.

https://doi.org/10.1182/blood.V130.Suppl_1.1793.1793

Published: 2017

Journal Articles

Functional Assessment (FA) in Multiple Myeloma (MM) Patients Predicts Survival: Use of Most Valuable Comorbidity Scores and Functional Tests in a German Study Group (Deutsche Studiengruppe Multiples Myelom [DSMM]) Incentive

Sophia Scheubeck, Gabriele Ihorst, Sandra M. Dold, MSc, Katja Schoeller, Martin Boeker, PD, Stefan J. Müller, PharmD, Johannes M. Waldschmidt, MD, Rebeka Javorniczky, MD, Alessandra Larocca, Margrit Ott, MD, Hermann Einsele, Justus Duyster, Ralph Wäsch, MD, Monika Engelhardt

Blood (2017) 130 (Supplement 1): 3436.

https://doi.org/10.1182/blood.V130.Suppl_1.3436.3436

Published: 2017

Journal Articles

Signal integration at the PI3K-p85-XBP1 hub endows coagulation protease activated protein C with insulin-like function

Blood (2017) 130 (12): 1445–1455.

https://doi.org/10.1182/blood-2017-02-767921

Published: 2017

Includes: Supplemental data

Journal Articles

Functional Geriatric Assessment (F-GA) in Multiple Myeloma Patients: Results from a Prospective Multicenter Study Group (DSMM) Trial and Changes from Baseline to Follow-up Assessment

Sophia Scheubeck, Sandra Maria Dold, M. Sc., Gabriele Ihorst, PhD, Alexander Zober, MD, Stefan J. Müller, Dipl.-Pharm., Christian Langer, MD, Wolfram Pönisch, Lars-Olof Mügge, MD, Stefan Knop, MD, Justus Duyster, MD, Martin Schumacher, PhD, Ralph M. Waesch, MD, Monika Engelhardt, MD

Blood (2016) 128 (22): 5627.

https://doi.org/10.1182/blood.V128.22.5627.5627

Published: 2016

Journal Articles

Testing Novel Anti - Multiple Myeloma (MM) Agents in a Suitable Three-Dimensional (3D) Co-Culture Platform

Stefan J. Müller, Dipl.-Pharm., Johannes M. Waldschmidt, MD, Johanna Senger, PhD, Dagmar Wider, Andreas R. Thomsen, MD, Gabriele Ihorst, PhD, Justus Duyster, MD, Martin J. Hug, PhD, Manfred Jung, PhD, Ralph Wäsch, MD, Monika Engelhardt, MD PhD

Blood (2016) 128 (22): 2109.

https://doi.org/10.1182/blood.V128.22.2109.2109

Published: 2016

Journal Articles

Loss of NFAT2 Leads to an Acceleration of Clonal Evolution in CLL

David J Müller, Melanie Märklin, PhD, Lothar Kanz, MD, Martin R Mueller, MD PhD, Stefan Wirths, MD

Blood (2016) 128 (22): 4369.

https://doi.org/10.1182/blood.V128.22.4369.4369

Published: 2016

Journal Articles

PIM1-Mediated CXCR4 Phosphorylation: A Potentially Class-Distinct Therapeutic Target of Next Generation Proteasome Inhibitors in Multiple Myeloma

Johannes M. Waldschmidt, MD, Dagmar Wider, Stefan J. Müller, Dipl.-Pharm., Anna Simon, Sarah Decker, PhD, Marie Follo, PhD, Justus Duyster, MD PhD, Ralph Wäsch, MD, Monika Engelhardt, MD PhD

Blood (2016) 128 (22): 2774.

https://doi.org/10.1182/blood.V128.22.2774.2774

Published: 2016

Journal Articles

How many dendritic cells are required to initiate a T-cell response?

Susanna Celli, Mark Day, Andreas J. Müller, Carmen Molina-Paris, Grant Lythe, Philippe Bousso

Blood (2012) 120 (19): 3945–3948.

https://doi.org/10.1182/blood-2012-01-408260

Published: 2012

Includes: Multimedia, Supplemental data

Journal Articles

Tyrosine nitration limits stretch-induced CD40 expression and disconnects CD40 signaling in human endothelial cells

Andreas H. Wagner, Anke Hildebrandt, Sebastian Baumgarten, Andreas Jungmann, Oliver J. Müller, Victor S. Sharov, Christian Schöneich, Markus Hecker

Blood (2011) 118 (13): 3734–3742.

https://doi.org/10.1182/blood-2010-11-320259

Published: 2011

Includes: Supplemental data

Journal Articles

Hepatocyte Growth Factor/Scatter Factor Promotes Adhesion of Lymphoma Cells to Extracellular Matrix Molecules Via α 4 β 1 and α 5 β 1 Integrins

Iris S. Weimar, Daphne de Jong, Egbert J. Muller, Toshikazu Nakamura, Joost M.H.H. van Gorp, Gijsbert C. de Gast, Winald R. Gerritsen

Blood (1997) 89 (3): 990–1000.

https://doi.org/10.1182/blood.V89.3.990

Published: 1997

Journal Articles

Target-induced death by apoptosis in human lymphokine-activated natural killer cells

K Taga, A Yamauchi, K Kabashima, ET Bloom, J Muller, G Tosato

Blood (1996) 87 (6): 2411–2418.

https://doi.org/10.1182/blood.V87.6.2411.bloodjournal8762411

Published: 1996

Journal Articles

Hb I Trait in an Algerian Mussulman Family, Presenting Two Abnormal Components

Cl. Boulard, A. Cosset, F. Destaing, A. Duzer, J. H. P. Jonxis, C. J. Muller, A. Portier

Blood (1961) 18 (6): 750–757.

https://doi.org/10.1182/blood.V18.6.750.750

Published: 1961

NARROW

Navigating the Changing Multiple Myeloma (MM) Treatment Landscape: Real-World Data on Clinical Practice Patterns in 287 MM Patients Treated in and Outside German DSMM (Deutsche Studiengruppe Multiples Myelom) Study Group Trials

Epigenetic Modifications of the Bone Marrow (BM) Niche in Multiple Myeloma (MM) - a Three-Dimensional (3D) in Vitro Approach

Functional Assessment (FA) in Multiple Myeloma (MM) Patients Predicts Survival: Use of Most Valuable Comorbidity Scores and Functional Tests in a German Study Group (Deutsche Studiengruppe Multiples Myelom [DSMM]) Incentive

Signal integration at the PI3K-p85-XBP1 hub endows coagulation protease activated protein C with insulin-like function

Functional Geriatric Assessment (F-GA) in Multiple Myeloma Patients: Results from a Prospective Multicenter Study Group (DSMM) Trial and Changes from Baseline to Follow-up Assessment

Testing Novel Anti - Multiple Myeloma (MM) Agents in a Suitable Three-Dimensional (3D) Co-Culture Platform

Loss of NFAT2 Leads to an Acceleration of Clonal Evolution in CLL

PIM1-Mediated CXCR4 Phosphorylation: A Potentially Class-Distinct Therapeutic Target of Next Generation Proteasome Inhibitors in Multiple Myeloma

How many dendritic cells are required to initiate a T-cell response?

Tyrosine nitration limits stretch-induced CD40 expression and disconnects CD40 signaling in human endothelial cells

Hepatocyte Growth Factor/Scatter Factor Promotes Adhesion of Lymphoma Cells to Extracellular Matrix Molecules Via α 4 β 1 and α 5 β 1 Integrins

Target-induced death by apoptosis in human lymphokine-activated natural killer cells

Hb I Trait in an Algerian Mussulman Family, Presenting Two Abnormal Components

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only